Images are character representations of Demodex mites.
Treat the Eyelid Mite Party: Discover the XDEMVY® Effect
Images are character representations of Demodex mites.
One drop per eye, twice a day (~12 hours apart), for 6 weeks.
XDEMVY Targets and Kills the Mites That Cause Demodex Blepharitis (DB)
XDEMVY was created specifically to treat Demodex blepharitis
XDEMVY is the first and only FDA-approved treatment for DB.1,2
One drop per eye, twice a day (~12 hours apart), for 6 weeks.
-
One drop per eye, twice a day, approximately 12 hours apart, in just 6 weeks
In two combined studies, 50% of patients had a reduction of crusties (collarettes) and 60% of patients had their Demodex mites completely wiped out.3*
Before XDEMVY
After XDEMVY
Images are of actual patient who participated in clinical trials for Tarsus Pharmaceuticals. Results may vary.
Patient with DB used XDEMVY twice daily, in each eye for 6 weeks. -
Designed for patient comfort
~90% of patients in both trials reported XDEMVY eye drops as neutral to very comfortable to use.3†
-
Stay on top of your treatment
It’s important to use XDEMVY for the full six weeks.
-
Reduce eyelid redness
Patients using XDEMVY for DB may see eyelid redness gone in just 6 weeks.1,2
XDEMVY for Demodex blepharitis was evaluated in 2 pivotal trials of 833 patients (415 received XDEMVY).2,4,5
Trial 1: When taken twice daily in each eye for 6 weeks, compared to those who did not receive XDEMVY, XDEMVY reduced collarettes to 2 or less for the upper eyelid in 44% of patients (N=209) at Day 43; XDEMVY eradicated mites (mite density of 0 mites/lash) in 68% of patients (N=212) at Day 43.
Trial 2: When taken twice daily in each eye for 6 weeks, compared to those who did not receive XDEMVY, XDEMVY reduced collarettes to 2 or less for the upper eyelid in 55% of patients (N=193) at Day 43; XDEMVY eradicated mites (mite density of 0 mites/lash) in 50% of patients (N=203) at Day 43.
†All visits averaged.3
XDEMVY SUCCESS STORIES
See how others have found relief from Demodex blepharitis with XDEMVY.
Spotlight Your XDEMVY Experience
Empower the DB community by sharing your personal experience.
Real Results
With XDEMVY
View the transformative effect of XDEMVY on Demodex blepharitis after using twice daily, in each eye, for 6 weeks.
One drop per eye, twice a day (~12 hours apart), for 6 weeks.
References: 1. XDEMVY Pivotal Trial Data Presentation. Tarsus Pharmaceuticals Inc. 2. XDEMVY. Prescribing Information. Tarsus Pharmaceuticals Inc; 2023. 3. Yeu E, Mun J, Vollmer P, et al. Treatment of Demodex blepharitis with lotilaner ophthalmic solution (0.25%): combined analysis of two pivotal randomized, vehicle-controlled, multicenter trials. Presented at: ARVO 2023; April 25-27, 2023; New Orleans, Louisiana. 4. Gaddie IB, Donnenfeld ED, Karpecki P, et al. Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2) [published online ahead of print, 2023 Jun 5]. Ophthalmology. 2023;S0161-6420(23)00392-5. 5. Yeu E, Wirta DL, Karpecki P, Baba SN, Holdbrook M; Saturn I Study Group. Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1). Cornea. 2023;42(4):435-443.